Share Name | Share Symbol | Market | Type |
---|---|---|---|
BriaCell Therapeutics Corp | TSX:BCT | Toronto | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.55 | 0.52 | 0.59 | 0 | 12:38:18 |
TORONTO, Feb. 10, 2022 /CNW/ - Dr. Bill Williams, President and Chief Executive Officer, BriaCell Therapeutics Corp. ("BriaCell" or the "Company") (TSX: BCT) and his team joined Arne Gulstene, Head, TSX Company Services, Toronto Stock Exchange, to celebrate the Company's graduation to Toronto Stock Exchange and open the market.
BriaCell is an immuno-oncology focused biotechnology company developing targeted and effective approaches for the management of cancer. More information is available at https://briacell.com/.
For Market Openings: Media may pick up a feed from the TOC (television operations centre) for all market open ceremonies. The feed is named TSX Transmit 1 (SD-SDI) and is produced at the TMX Broadcast Centre and sent live to the TOC. To pick up the feed via the Dejero network, please contact avservices@tmx.com. The client feature video will begin playing on the TMX media wall at approximately 9:27 a.m. ET and the markets will open with the sound of a siren at 9:30 a.m. ET
Date: Thursday February 10, 2022
Time: 9:00am - 9:30am
Place: Virtually Broadcast
SOURCE Toronto Stock Exchange
Copyright 2022 Canada NewsWire
1 Year BriaCell Therapeutics Chart |
1 Month BriaCell Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions